CORD-19:e847d433e7424152a9846673209cb73027415ecd / 425097-425320 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3903","span":{"begin":0,"end":223},"obj":"Sentence"},{"id":"T27695","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Management of therapy for hepatitis C virus (HCV) infection is based on quantitative measurement of HCV RNA and the decision of treatment discontinuation on the basis of a 2 log decline at week 12 is a widely accepted rule."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T365","span":{"begin":0,"end":223},"obj":"Sentence"}],"text":"Management of therapy for hepatitis C virus (HCV) infection is based on quantitative measurement of HCV RNA and the decision of treatment discontinuation on the basis of a 2 log decline at week 12 is a widely accepted rule."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1410","span":{"begin":26,"end":37},"obj":"Disease"},{"id":"T1411","span":{"begin":26,"end":35},"obj":"Disease"},{"id":"T1412","span":{"begin":50,"end":59},"obj":"Disease"},{"id":"T17679","span":{"begin":26,"end":37},"obj":"Disease"},{"id":"T10148","span":{"begin":26,"end":35},"obj":"Disease"},{"id":"T41881","span":{"begin":50,"end":59},"obj":"Disease"}],"attributes":[{"id":"A1410","pred":"mondo_id","subj":"T1410","obj":"http://purl.obolibrary.org/obo/MONDO_0005231"},{"id":"A1411","pred":"mondo_id","subj":"T1411","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A1412","pred":"mondo_id","subj":"T1412","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A87108","pred":"mondo_id","subj":"T17679","obj":"http://purl.obolibrary.org/obo/MONDO_0005231"},{"id":"A24644","pred":"mondo_id","subj":"T10148","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A46524","pred":"mondo_id","subj":"T41881","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Management of therapy for hepatitis C virus (HCV) infection is based on quantitative measurement of HCV RNA and the decision of treatment discontinuation on the basis of a 2 log decline at week 12 is a widely accepted rule."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T495","span":{"begin":26,"end":35},"obj":"Phenotype"}],"attributes":[{"id":"A495","pred":"hp_id","subj":"T495","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"Management of therapy for hepatitis C virus (HCV) infection is based on quantitative measurement of HCV RNA and the decision of treatment discontinuation on the basis of a 2 log decline at week 12 is a widely accepted rule."}